PHM12 COST-EFFECTIVENESS OF DASATINIBVS IMATINIB 800 MG/ DAY IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA IN SPAIN
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65039-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65039-5/fulltext
Section Title :
Section Order :
198
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65039-5&doi=10.1016/S1098-3015(10)65039-5